BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37056286)

  • 21. Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway.
    Yang JJ; Yang Y; Zhang C; Li J; Yang Y
    J Cell Mol Med; 2020 Feb; 24(4):2677-2687. PubMed ID: 31961061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of hepatic stellate cell activation.
    Mann DA; Mann J
    J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S108-11. PubMed ID: 18336652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells.
    Tian W; Hao C; Fan Z; Weng X; Qin H; Wu X; Fang M; Chen Q; Shen A; Xu Y
    J Hepatol; 2015 Jan; 62(1):165-74. PubMed ID: 25109772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation: new therapeutic implications for hepatic fibrosis.
    Bian EB; Huang C; Wang H; Wu BM; Zhang L; Lv XW; Li J
    Cell Signal; 2013 Jan; 25(1):355-8. PubMed ID: 23085259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of Smad7 mediated by DNMT1 determines hepatic stellate cell activation and liver fibrosis in rats.
    Bian EB; Huang C; Wang H; Chen XX; Zhang L; Lv XW; Li J
    Toxicol Lett; 2014 Jan; 224(2):175-85. PubMed ID: 24211420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-immediate gene Egr1 is associated with TGFβ1 regulation of epigenetic reader Bromodomain-containing protein 4 via the canonical Smad3 signaling in hepatic stellate cells in vitro and in vivo.
    Tian H; Xu F; Zhao F; Pan N; Lu S; Jia X; Zhou Y
    FASEB J; 2022 Nov; 36(11):e22605. PubMed ID: 36250963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.
    El Taghdouini A; van Grunsven LA
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1397-1408. PubMed ID: 27762150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.
    Zeybel M; Luli S; Sabater L; Hardy T; Oakley F; Leslie J; Page A; Moran Salvador E; Sharkey V; Tsukamoto H; Chu DCK; Singh US; Ponzoni M; Perri P; Di Paolo D; Mendivil EJ; Mann J; Mann DA
    Mol Ther; 2017 Jan; 25(1):218-231. PubMed ID: 28129116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gα
    Kim KM; Han CY; Kim JY; Cho SS; Kim YS; Koo JH; Lee JM; Lim SC; Kang KW; Kim JS; Hwang SJ; Ki SH; Kim SG
    J Hepatol; 2018 Mar; 68(3):493-504. PubMed ID: 29080810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the impact of hepatitis B virus on hepatic stellate cell activation.
    You H; Wang X; Ma L; Zhang F; Zhang H; Wang Y; Pan X; Zheng K; Kong F; Tang R
    Cell Commun Signal; 2023 Apr; 21(1):70. PubMed ID: 37041599
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
    Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells.
    Moran-Salvador E; Garcia-Macia M; Sivaharan A; Sabater L; Zaki MYW; Oakley F; Knox A; Page A; Luli S; Mann J; Mann DA
    Gastroenterology; 2019 Nov; 157(5):1398-1412.e9. PubMed ID: 31352003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis.
    He L; Yuan H; Liang J; Hong J; Qu C
    PLoS One; 2020; 15(5):e0233702. PubMed ID: 32442221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injury.
    Sharma S; Ghufran SM; Das B; Roy B; Ghose S; Biswas S
    Life Sci; 2021 Dec; 287():120119. PubMed ID: 34743004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-coding RNA-mediated epigenetic regulation of liver fibrosis.
    Yang JJ; Tao H; Deng ZY; Lu C; Li J
    Metabolism; 2015 Nov; 64(11):1386-94. PubMed ID: 26362725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury.
    Zhang W; Conway SJ; Liu Y; Snider P; Chen H; Gao H; Liu Y; Isidan K; Lopez KJ; Campana G; Li P; Ekser B; Francis H; Shou W; Kubal C
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives.
    Yang JJ; Tao H; Li J
    Expert Opin Ther Targets; 2014 Sep; 18(9):1011-21. PubMed ID: 24935558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.